Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Ajanta Pharma Limited
AJANTPHARM | NSE
2,968.80
INR-7.70
-0.26%
AJANTPHARM | NSE
Loading StockChartView...
About Ajanta Pharma Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
08/06/2026
Close
2,968.80
Open
2,945.10
High
3,046.00
Low
2,945.00
Ajanta Pharma Limited a specialty pharmaceutical formulation company together with its subsidiaries develops manufactures and markets finished dosages. The company markets and serves various therapeutic segments such as anti-biotic anti-malarial diabetic cardiology gynecology respiratory and general health products dermatology and pain management areas. It also provides tablets capsules powder liquid jelly ointments eye drops active pharma ingredient. The company serves in India Africa rest of Asia the United States and internationally. The company was founded in 1973 and is headquartered in Mumbai India.
View LessAJANTPHARM | NSE
Risk
27.1
Sharpe
0.45
Luna's Score
69/100
Recommendation
Buy
Luna says (AJANTPHARM | NSE)
What's Working
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Operating Margin (> 25%)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
Midcap (2B - 10B USD)
Rich in Valuation (Price to Book > 8)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
21.5%1 month
27.1%3 months
31.3%6 months
27.8%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
47.17
Fwd. PE
-
Price to book
11.33
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
30.61
Ent. to rev.
9.36
PEG
-
Other Fundamentals
EBITDA
12.23B
MarketCap
376.03B
MarketCap(USD)
3.93B
Div. yield
1.13
Op. margin
25.89
Erngs. growth
18.10
Rev. growth
12.10
Ret. on equity
23.47
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
287.30
Range1M
464.90
Range3M
618.30
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.80
Price X volume
325.05M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 30.61 | 24.85 | Expensive |
| Ent. to Revenue | 9.36 | 11.40 | Par |
| PE Ratio | 47.17 | 51.36 | Par |
| Price to Book | 11.33 | 6.83 | Expensive |
| Dividend Yield | 1.13 | 0.52 | Leader |
| Std. Deviation (3M) | 31.28 | 42.17 | Lower Risk |
| Debt to Equity | 0.01 | 0.35 | Cheaper |
| Debt to Assets | 0.01 | 0.17 | Cheaper |
| Market Cap | 376.03B | 290.82B | Market Leader |
